Correlation between the severity of coronary artery disease and the plasma levels of the soluble receptor of advanced glycation end products

被引：0
|
作者：
Dislian, V. [1 ,2 ]
Giannoglou, G. [2 ]
Hatzistilianou, M. [3 ]
Kouvelas, D. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Pharmacol, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Cardiol Dept 1, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Pediat 2, Thessaloniki, Greece
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2008年 / 377卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
504
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [31] Association of Soluble Receptor for Advanced Glycation End Products Levels with Hypertensive Albuminuria
    Zheng, Huan
    Yuan, Lingyan
    Xie, Nanzi
    Xu, Huifeng
    Xie, Xiaoyun
    Luo, Ming
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (02) : 259 - 264
  • [32] Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
    Manichaikul, Ani
    Sun, Li
    Borczuk, Alain C.
    Onengut-Gumuscu, Suna
    Farber, Emily A.
    Mathai, Susan K.
    Zhang, Weiming
    Raghu, Ganesh
    Kaufman, Joel D.
    Hinckley-Stukovsky, Karen D.
    Kawut, Steven M.
    Jelic, Sanja
    Liu, Wen
    Fingerlin, Tasha E.
    Schwartz, David A.
    Sell, Jessica L.
    Rich, Stephen S.
    Barr, R. Graham
    Lederer, David J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (05) : 628 - 635
  • [33] Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study
    Rebholz, Casey M.
    Astor, Brad C.
    Grams, Morgan E.
    Halushka, Marc K.
    Lazo, Mariana
    Hoogeveen, Ron C.
    Ballantyne, Christie M.
    Coresh, Josef
    Selvin, Elizabeth
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (01) : 77 - 83
  • [34] LOW SERUM LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IS NOT AN UNIVERSAL BIOMARKER FOR CARDIOVASCULAR DISEASE
    Prasad, K.
    CARDIOLOGY, 2017, 137 : 267 - 267
  • [35] Plasma levels of advanced glycation end products in children with renal disease
    K. Šebeková
    Ł. Podracká
    P. Blažíček
    D. Syrová
    A. Heidland
    R. Schinzel
    Pediatric Nephrology, 2001, 16 : 1105 - 1112
  • [36] Plasma levels of advanced glycation end products in children with renal disease
    Sebeková, K
    Podracká, L
    Blazícek, P
    Syrová, D
    Heidland, A
    Schinzel, R
    PEDIATRIC NEPHROLOGY, 2001, 16 (12) : 1105 - 1112
  • [37] Cilostazol attenuates the severity of peripheral arterial disease in type 2 diabetes: the plasma soluble receptor for advanced glycation end-products
    Liu, Jhih-Syuan
    Hung, Yi-Jen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S144 - S144
  • [38] ADVANCED GLYCATION END PRODUCTS, SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND RISK OF LIVER CANCER.
    Moy, K. A.
    Jiao, L.
    Freedman, N. D.
    Weinstein, S. J.
    Sinha, R.
    Virtamo, J.
    Albanes, D.
    Stolzenberg-Solomon, R. Z.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S103 - S103
  • [39] Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
    Pinto, Raphael S.
    Ferreira, Guilherme S.
    Silvestre, Gina Camillo R.
    Santana, Monique de Fatima M.
    Nunes, Valeria S.
    Ledesma, Lucas
    Pinto, Paula R.
    de Assis, Sayonara Ivana S.
    Machado, Ubiratan F.
    da Silva, Erasmo S.
    Passarelli, Marisa
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (01):
  • [40] Soluble receptor for advanced glycation end-products and progression of airway disease
    Iwamoto, Hiroshi
    Gao, Jing
    Pulkkinen, Ville
    Toljamo, Tuula
    Nieminen, Pentti
    Mazur, Witold
    BMC PULMONARY MEDICINE, 2014, 14
12345